Related Experiment Video
Updated: Feb 21, 2026
08:01
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
2.3K
Advances in systemic therapy for malignant mesothelioma: future perspectives
Navid Sobhani1,2, Silvia Paola Corona3, Deborah Bonazza2
1Department of Medical, Surgical, & Health Sciences, University of Trieste, Piazza Ospitale 1 34129 Trieste, Italy.
Future Oncology (London, England)
|October 7, 2017
Summary
Malignant mesothelioma, a rare cancer linked to asbestos, has poor survival rates. New research explores advanced treatments like targeted therapies and immunotherapies to improve patient outcomes.
Area of Science:
- Oncology
- Genetics
- Occupational Health
Background:
- Malignant mesothelioma is an aggressive cancer of the mesothelium, often linked to occupational asbestos exposure.
- Current standard treatments offer limited survival, averaging only 12 months.
- The disease incidence is increasing in regions with historical asbestos use.
Purpose of the Study:
- To review the latest advancements in malignant mesothelioma treatment.
- To highlight novel therapeutic strategies including chemotherapy combinations, molecular targets, and immunotherapies.
- To provide a comprehensive overview of current and future treatment options.
Main Methods:
- Literature review of recent research on malignant mesothelioma.
- Analysis of next-generation sequencing data for tumor mutational landscapes.
- Focus on emerging treatment modalities and their efficacy.
Main Results:
- Next-generation sequencing enables detailed study of tumor genetics.
- New combinatorial chemotherapy regimens show promise.
- Molecular targets and immunotherapies represent significant therapeutic advancements.
Conclusions:
- Understanding the genetic drivers of mesothelioma is crucial for targeted treatment.
- Emerging therapies offer new hope for improving survival and quality of life for patients.
- A multi-faceted approach combining chemotherapy, targeted therapy, and immunotherapy is key to future treatment strategies.
Keywords:
asbestoscombinatorial chemotherapyepithelioid mesotheliomaimmunotherapymalignant mesotheliomatargeted therapyMore Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:49Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K